Oncotelic Therapeutics, Inc. (OTCPK: OTLC)
Health Care · Biotechnology · US
$0.02
-17.00% today · -74.1% 1Y
Oncotelic Therapeutics, Inc. (OTCPK: OTLC) operates in the Biotechnology industry within the Health Care sector. The company is valued at $9.61M and employs 41 people.
Over the last twelve months the share price has lost 74.1%, trading between 0.02 and 0.11.
Tweenvest scores Oncotelic Therapeutics, Inc. across four factors: quality 42/100, value 32/100. Its strongest factor is quality.
OTLC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.61M
- Revenue (TTM)
- $250.00K
- P/E
- 0.04
- EPS
- 0.56
- Dividend yield
- —
- Beta (5Y)
- -0.18
- 52-week high
- $0.11
- 52-week low
- $0.02
- Avg volume (3M)
- —
- Shares outstanding
- 457.51M
- Employees
- 41
- Next earnings
- —
About Oncotelic Therapeutics, Inc.
Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage biopharmaceutical company, specializes in developing therapeutics for rare oncological conditions. Its flagship therapeutic candidate, OT-101 – an antisense compound designed to inhibit TGF-ß2 – is currently undergoing Phase 3 clinical trials for both pancreatic cancer and glioblastoma. Beyond oncology, OT-101 is also being explored for its potential in treating various viral diseases, including severe acute respiratory syndrome (SARS) and coronaviruses. The company's pipeline further includes OXi4503, which is being advanced for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), and CA4P, intended for the treatment of advanced metastatic melanoma.
- ISIN
- US6283411097
- Listed since
- Aug 26, 1993
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Active Biotech AB (publ)OM: ACTI | $9.96M | Skr3.79 | -10.82% |
| Adaptimmune Therapeutics plcOTCPK: ADAP.Y | $9.81M | $0.04 | +45.10% |
| Zeo ScientifiX, Inc.OTCPK: ZEOX | $9.80M | $1.25 | -8.09% |
| CRISM Therapeutics CorporationAIM: CRTX | $9.69M | £0.09 | -5.13% |
| NFL Biosciences SAENXTPA: ALNFL | $9.54M | €0.67 | -10.32% |
| Moleculin Biotech, Inc.NasdaqCM: MBRX | $9.48M | $0.42 | -12.90% |
| PeopleBio, Inc.KOSDAQ: A304840 | $9.47M | ₩— | — |
| Celestra Inc.KOSDAQ: A352770 | $9.28M | ₩— | — |
Figures last refreshed Oct 4, 2026.